The Directorate General of Customs Valuation Karachi has issued a fresh valuation ruling revising customs values for the import of blood collection tubes from China, following a legal challenge to an earlier assessment.
According to the new ruling, the updated customs values apply to blood collection tubes manufactured from both glass and PET (plastic) materials, which are widely used in diagnostic laboratories and hospitals across Pakistan.
Earlier Ruling Challenged
The previous import values had been fixed under Valuation Ruling No. 2017 of 2025 in accordance with Section 25A of the Customs Act, 1969. However, importers contested the valuation and filed a revision petition before the Director General under Section 25D of the same law.
After reviewing the case, the Director General rescinded the earlier ruling through an Order in Revision issued on October 31, 2025, directing customs authorities to conduct a fresh valuation exercise based on updated market evidence and stakeholder submissions.
Stakeholder Consultations Held
During the reassessment process, customs officials held consultations with both local manufacturers and importers.
Local manufacturers argued that customs values should be increased to reflect prevailing international market prices and submitted export documentation in support of their claims.
Customs authorities examined the submissions alongside 90 days of import data, evaluating transaction trends, pricing patterns, and declared import values.
Officials noted that many export documents presented by manufacturers were more than a year old and related largely to exports destined for markets other than Pakistan. Authorities also attempted to verify pricing information directly with China-based suppliers, but received no response.
Final Valuation Determined
Following detailed analysis, customs authorities finalized the revised valuation under Section 25(9) of the Customs Act, 1969, calculating updated Cost and Freight (C&F) values in line with applicable legal provisions and the Customs Rules, 2001.
The revised valuation is expected to standardize import assessments, reduce disputes at ports, and ensure uniform duty collection on medical diagnostic equipment entering Pakistan.
